Nancy Globus, Vice President for Regulatory and Medicine Safety, Addison Whitney, talks medication safety, product labelling and errors.

Looking forward to the year ahead, GOLD casts five predictions for what the standout advancements and priorities will be for pharma in 2021.

Karen Moyse, Founder and Managing Director, KineticFuture Leadership, discusses best practices for managing conflicting personalities.

Isma Benattia, Vice President Europe Medical Affairs, Amgen talks about harnessing technology to unlock better outcomes for patients.

Arun Mahtani, Former Vice President, Channels Strategy and Digital Content, Teva Pharmaceuticals, talks about impactful patient initiatives.

Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva, discusses unlocking further potential in developed markets.

Pierre Bourdage, Global Head Biopharmaceuticals, Sandoz, provides insight into the state and future of the biosimilars market.

Patrick Romano, Co-founder and Partner, Eradigm Consulting, talks about his experience as a biochemist, how to build pharmaceutical value propositions fit for the future, and how the industry can navigate the blurring of lines between pharma and public health.